These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11693513)

  • 1. Cost analysis of two strategies for preventing hepatitis A virus infection in Spanish travellers to developing countries.
    Bayas JM; González A; Vilella A; San-Martín M; Bertran MJ; Adell C
    Epidemiol Infect; 2001 Oct; 127(2):347-51. PubMed ID: 11693513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of two strategies for hepatitis A vaccination of hospital health-care personnel in an intermediate endemicity area.
    de Juanes JR; González A; Arrazola MP; San-Martín M
    Vaccine; 2001 Jul; 19(30):4130-4. PubMed ID: 11457537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of the prevaccination detection of anti-HAV in hepatitis A vaccination programs].
    Navas E; Bayas JM; Bruguera M; Vidal J; Galí N; Taberner JL; Salleras L
    Med Clin (Barc); 1995 Jul; 105(5):168-71. PubMed ID: 7630228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination strategies against hepatitis A in travelers older than 40 years: an economic evaluation.
    Costas L; Vilella A; Trilla A; Serrano B; Vera I; Roldán M; Sancho MP; Bayas JM; Gascón J; Costa J
    J Travel Med; 2009; 16(5):344-8. PubMed ID: 19796106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of hepatitis A antibodies among Israeli travellers and the economic feasibility of screening before vaccination.
    Schwartz E; Raveh D
    Int J Epidemiol; 1998 Feb; 27(1):118-20. PubMed ID: 9563704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis A antibody titres after infection and immunization: implications for passive and active immunization.
    Zaaijer HL; Leentvaar-Kuijpers A; Rotman H; Lelie PN
    J Med Virol; 1993 May; 40(1):22-7. PubMed ID: 8515245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of vaccination against hepatitis A in travellers.
    Van Doorslaer E; Tormans G; Van Damme P
    J Med Virol; 1994 Dec; 44(4):463-9. PubMed ID: 7897383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of hepatitis A prevention in travellers.
    Tormans G; Van Damme P; Van Doorslaer E
    Vaccine; 1992; 10 Suppl 1():S88-92. PubMed ID: 1335668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening policy for travellers from Rotterdam for hepatitis A antibodies prior to eventual immunization: favourable cost-benefit ratio].
    Reintjes R; Bosman A; de Zwart O
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1777-80. PubMed ID: 10494329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.
    Ramsay LC; Anyiwe K; Li M; Macdonald L; Coyte PC; Sander B
    Vaccine; 2019 Mar; 37(11):1467-1475. PubMed ID: 30770225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HAV seroprevalence in German travellers and hepatitis A vaccination in immune subjects.
    Bienzle U; Bock HL; Meister W; Clemens R; Kruppenbacher JP
    Lancet; 1993 Apr; 341(8851):1028. PubMed ID: 8096914
    [No Abstract]   [Full Text] [Related]  

  • 13. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HAV & HBV vaccination among travellers participating in the National Health and Wellness Survey in five European countries.
    Pedersini R; Marano C; De Moerlooze L; Chen L; Vietri J
    Travel Med Infect Dis; 2016; 14(3):221-32. PubMed ID: 27000975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effective analysis of hepatitis A prevention in Ireland.
    Rajan E; Shattock AG; Fielding JF
    Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis A vaccines.
    Nothdurft HD
    Expert Rev Vaccines; 2008 Jul; 7(5):535-45. PubMed ID: 18564009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two vaccination strategies against hepatitis A and B in patients with chronic hepatitis C.
    Díez Redondo MP; Almaraz A; Jiménez Rodríguez-Vila M; Santamaría A; de Castro J; Torrego JC; Caro-Patón A
    Rev Esp Enferm Dig; 2009 Apr; 101(4):265-74. PubMed ID: 19492902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of anti-hepatitis A IgG in a cohort of UK HIV-negative men who have sex with men: implications for local hepatitis A vaccine policy.
    Bhagey A; Foster K; Ralph S; Wardropper A; White C; Wholey V; Duncan S
    Int J STD AIDS; 2018 Sep; 29(10):1007-1010. PubMed ID: 29743003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.